Publicaciones en colaboración con investigadores/as de Novartis (Sweden) (3)

2021

  1. Efficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trial

    Rheumatology (United Kingdom), Vol. 60, Núm. 1, pp. 256-262

2011

  1. Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study

    BMC Musculoskeletal Disorders, Vol. 12

2010

  1. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis

    Science Translational Medicine, Vol. 2, Núm. 52